142 related articles for article (PubMed ID: 11045393)
1. Hemolytic uremic syndrome associated with Denys-Drash syndrome.
Sherbotie JR; van Heyningen V; Axton R; Williamson K; Finn LS; Kaplan BS
Pediatr Nephrol; 2000 Oct; 14(12):1092-7. PubMed ID: 11045393
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
[TBL] [Abstract][Full Text] [Related]
3. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
4. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.
Alge JL; Wenderfer SE; Hicks J; Bekheirnia MR; Schady DA; Kain JS; Braun MC
BMC Nephrol; 2017 Jul; 18(1):243. PubMed ID: 28720077
[TBL] [Abstract][Full Text] [Related]
6. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
7. Nephrotic syndrome and end-stage renal disease with WT1 mutation detected at 3 years.
Ito S; Ikeda M; Takata A; Kikuchi H; Hata J; Honda M
Pediatr Nephrol; 1999 Nov; 13(9):790-1. PubMed ID: 10603123
[TBL] [Abstract][Full Text] [Related]
8. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
Tsuda M; Sakiyama T; Owada M; Chiba Y
Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
[TBL] [Abstract][Full Text] [Related]
9. WT1 and glomerular diseases.
Niaudet P; Gubler MC
Pediatr Nephrol; 2006 Nov; 21(11):1653-60. PubMed ID: 16927106
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
[TBL] [Abstract][Full Text] [Related]
11. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes.
Breslow NE; Takashima JR; Ritchey ML; Strong LC; Green DM
Cancer Res; 2000 Aug; 60(15):4030-2. PubMed ID: 10945603
[TBL] [Abstract][Full Text] [Related]
12. Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases.
Denamur E; Bocquet N; Mougenot B; Da Silva F; Martinat L; Loirat C; Elion J; Bensman A; Ronco PM
J Am Soc Nephrol; 1999 Oct; 10(10):2219-23. PubMed ID: 10505700
[TBL] [Abstract][Full Text] [Related]
13. [A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy].
Yamamoto K; Santo Y; Satomura K
Nihon Jinzo Gakkai Shi; 2003; 45(1):42-6. PubMed ID: 12680320
[TBL] [Abstract][Full Text] [Related]
14. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome.
Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H
Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902
[No Abstract] [Full Text] [Related]
15. WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.
Kanemoto K; Ishikura K; Ariyasu D; Hamasaki Y; Hataya H; Hasegawa Y; Ikeda M
Pediatr Nephrol; 2007 Mar; 22(3):454-8. PubMed ID: 17061122
[TBL] [Abstract][Full Text] [Related]
16. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
[TBL] [Abstract][Full Text] [Related]
17. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
[TBL] [Abstract][Full Text] [Related]
18. A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.
Benetti E; Caridi G; Malaventura C; Dagnino M; Leonardi E; Artifoni L; Ghiggeri GM; Tosatto SC; Murer L
Clin J Am Soc Nephrol; 2010 Apr; 5(4):698-702. PubMed ID: 20150449
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum of Denys-Drash and Frasier syndrome.
McTaggart SJ; Algar E; Chow CW; Powell HR; Jones CL
Pediatr Nephrol; 2001 Apr; 16(4):335-9. PubMed ID: 11354777
[TBL] [Abstract][Full Text] [Related]
20. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
Machin GA
Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
[No Abstract] [Full Text] [Related]
[Next] [New Search]